To support our strategy of choosing CD44 as a potential receptor for effective antitumor targeting in cervical cancer specifically, the role of CD44 expression in cervical cancer in overall survival and disease-free survival of patients was also analyzed. The gene discussed is CD44; the disease is cervical carcinoma.